1. Academic Validation
  2. A Chemical-Genetic Approach to Generate Selective Covalent Inhibitors of Protein Kinases

A Chemical-Genetic Approach to Generate Selective Covalent Inhibitors of Protein Kinases

  • ACS Chem Biol. 2017 Jun 16;12(6):1499-1503. doi: 10.1021/acschembio.6b01083.
Alvin Kung Marianne Schimpl 1 Arunika Ekanayake Ying-Chu Chen Ross Overman 2 Chao Zhang
Affiliations

Affiliations

  • 1 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Building 310, Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, United Kingdom.
  • 2 Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca , Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom.
Abstract

Although a previously developed bump-hole approach has proven powerful in generating specific inhibitors for mapping functions of protein kinases, its application is limited by the intolerance of the large-to-small mutation by certain kinases and the inability to control two kinases separately in the same cells. Herein, we describe the development of an alternative chemical-genetic approach to overcome these limitations. Our approach features the use of an engineered cysteine residue at a particular position as a reactive feature to sensitize a kinase of interest to selective covalent blockade by electrophilic inhibitors and is thus termed the Ele-Cys approach. We successfully applied the Ele-Cys approach to identify selective covalent inhibitors of a receptor tyrosine kinase EphB1 and solved cocrystal structures to determine the mode of covalent binding. Importantly, the Ele-Cys and bump-hole approaches afforded orthogonal inhibition of two distinct kinases in the cell, opening the door to their combined use in the study of multikinase signaling pathways.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-115481
    99.87%, EphB1 Inhibitor